DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Frequency defined:  

1-10% 

Upper respiratory tract infection (7%) 

Back pain (3%) 

Sinusitis (3%) 

Diarrhea (3%) 

Cough (1.6%) 

Pharyngitis (1%)  

Frequently undefined: 

Angina pectoris 

Tachycardia 

Arthritis 

Anxiety 

Asthma 

Eczema 

Cystitis 

Depression 

Gastritis 

Otitis media 

Pruritus 

Urticaria 

Vomiting 

xerostomia 

Be cautious in patients with hypersensitivity to telmisartan and co-administration of aliskiren in diabetic patients 

Pregnancy consideration:  

Not recommended to use in pregnancy 

Pregnancy category: D  

Lactation: The excretion of the drug in human breast milk is unknown  

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: There is no evidence of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women. 
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh risks over benefits These category drugs should be prohibited for pregnant women. 
• Category N: No data is available for the drug under this category. 

Patient information leaflet 

Generic Name: telmisartan 

Pronounced: [ TEL-mi-SAR-tan ] 

Why do we use telmisartan? 

Telmisartan is an angiotensin II receptor block used to treat hypertension.